2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)-3-methoxyphenyl)acetamide

ID: ALA4463672

Chembl Id: CHEMBL4463672

PubChem CID: 151160913

Max Phase: Preclinical

Molecular Formula: C27H22ClF3N2O5

Molecular Weight: 546.93

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc2nccc(Oc3ccc(NC(=O)Cc4ccc(Cl)c(C(F)(F)F)c4)cc3OC)c2cc1OC

Standard InChI:  InChI=1S/C27H22ClF3N2O5/c1-35-23-12-16(33-26(34)11-15-4-6-19(28)18(10-15)27(29,30)31)5-7-22(23)38-21-8-9-32-20-14-25(37-3)24(36-2)13-17(20)21/h4-10,12-14H,11H2,1-3H3,(H,33,34)

Standard InChI Key:  NAFZHCDEVMHMTO-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4463672

    ---

Associated Targets(Human)

KIT Tclin Stem cell growth factor receptor (10667 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Kit Mast/stem cell growth factor receptor Kit (47 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 546.93Molecular Weight (Monoisotopic): 546.1169AlogP: 6.91#Rotatable Bonds: 8
Polar Surface Area: 78.91Molecular Species: NEUTRALHBA: 6HBD: 1
#RO5 Violations: 2HBA (Lipinski): 7HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: 13.95CX Basic pKa: 5.84CX LogP: 5.71CX LogD: 5.70
Aromatic Rings: 4Heavy Atoms: 38QED Weighted: 0.26Np Likeness Score: -1.12

References

1. Wu Y, Wang B, Wang J, Qi S, Zou F, Qi Z, Liu F, Liu Q, Chen C, Hu C, Hu Z, Wang A, Wang L, Wang W, Ren T, Cai Y, Bai M, Liu Q, Liu J..  (2019)  Discovery of 2-(4-Chloro-3-(trifluoromethyl)phenyl)-N-(4-((6,7-dimethoxyquinolin-4-yl)oxy)phenyl)acetamide (CHMFL-KIT-64) as a Novel Orally Available Potent Inhibitor against Broad-Spectrum Mutants of c-KIT Kinase for Gastrointestinal Stromal Tumors.,  62  (13): [PMID:31250638] [10.1021/acs.jmedchem.9b00280]

Source